Individualized Diabetes Education Assisted by CGM (IDEA-CGM) for Type 2 Diabetes

This study is looking at how different types of diabetes education, some using a continuous glucose monitor (CGM) and some not, affect people with type 2 diabetes. You might receive personalized nutrition counseling based on CGM data, standard nutrition education, or general diabetes education with or without CGM. The study wants to see if these approaches can help lower your Hemoglobin A1c (a measure of blood sugar control) after 12 weeks. To join, you need to be at least 18 years old, have type 2 diabetes, and an HbA1c between 6.8% and 8.5%. You cannot participate if you have type 1 diabetes, use insulin or certain other medications, or have a BMI below 25 (or 23 for Asian participants).

Study design
This interventional study plans to enroll 72 participants. It compares different types of behavioral interventions, some using unblinded CGM and some blinded (meaning you wouldn't see your glucose data).
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 12 weeks, which suggests participants will be followed for at least that long.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06784375

Individualized Diabetes Education Assisted by CGM (IDEA-CGM)

Recruiting
NAAges 18+InterventionalTreatment
University of Minnesota
~72 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:Unblinded CGM/Nutrition TherapyBlinded CGM/Nutrition TherapyUnblinded CGM/No Nutrition TherapyBlinded CGM/No Nutrition Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hemoglobin A1c
Measured over 12 weeks
Type 2 Diabetes
1 sites across 1 states
Minnesota1
  • Anne Bantle · PRINCIPAL_INVESTIGATOR · University of Minnesota

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

at least 18 years of age
previous diagnosis of T2DM
HbA1c of 6.8-8.5%

Exclusion

type 1 diabetes mellitus
treatment with insulin, sulfonylurea, or meglitinide
use of nondiabetic medications that affect blood glucose control (such as corticosteroids)
BMI \<25 kg/m2 or \<23 kg/m2 for participants who self-identify as Asian
weight change \>5 pounds in the 3 months prior to study enrollment
estimated glomerular filtration rate \<60 ml/minute/1.73 m2
pregnancy or immediate plans to become pregnant 8) breastfeeding 9) anemia (which would affect measurement of HbA1c) 10) changes to glucose lowering medications, including change in dose, in the 3 months prior to enrollment 11) presence of any disease that would make adherence to the protocol difficult."
  • Hemoglobin A1c12 weeks

    Measure of blood glucose control